Hematology TimesFDA approves brentuximab vedotin for pcALCL, MFNovember 10, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesIbrutinib sustains efficacy in CLL at 4-year follow-upNovember 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCancer drug costs increasing despite competitionNovember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLALLNon-Hodgkin Lymphoma
Hematology TimesFDA approves drug to treat rel/ref MCLNovember 1, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCCSs more likely to stay at jobs to keep health insuranceOctober 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrug receives breakthrough designation for DLBCLOctober 25, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesEMA recommends orphan designation for G100 to treat FLOctober 24, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesNew assay may aid diagnosis, treatment of DLBCLOctober 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesWhat we don’t know about BIA-ALCLOctober 20, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCAR T-cell therapy approved to treat lymphomasOctober 19, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesGel shows promise for treating early stage MFOctober 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesNatural selection opportunities tied to cancer ratesOctober 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesNCCN completes resource on radiation therapyOctober 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesPredicting neurotoxicity after CAR T-cell therapyOctober 12, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesImmunotherapy demonstrates potential for T-cell lymphomaOctober 11, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
